Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficay of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma

  • Bohjanen, Kimberly (PI)

Project: Research project

Project Details

Description

Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficay of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma
StatusActive
Effective start/end date11/27/185/6/22

Funding

  • SOLIGENIX INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.